Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| PCFT | Q96NT5 | Proton-coupled folate transporter (HsPCFT) (hPCFT) (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1) | Disease related genesEssential proteinsHuman disease related genes | 12 | Folate deficiency anaemiaLeukaemiaNutritional deficiency | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.40 | ||
| PDE3A | Q14432 | cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE) | Disease related genesEnzymesFDA approved drug targets | 6 | Arterial occlusive diseaseAsthmaCardiovascular disease | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.40 | ||
| PE2R3 | P43115 | Prostaglandin E2 receptor EP3 subtype (PGE receptor EP3 subtype) (PGE2 receptor EP3 subtype) (PGE2-R) (Prostanoid EP3 receptor) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteins | 7 | AsthmaChronic arterial occlusive diseaseGlaucoma | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 1 | 0.40 | ||
| PGFRB | P09619 | Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b) | Cancer-related genesCD markersDisease related genes | 1 | Acute diabetic complicationAlzheimer diseaseGram-positive bacterial infection | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.40 | ||
| PI2R | P43119 | Prostacyclin receptor (Prostaglandin I2 receptor) (PGI receptor) (PGI2 receptor) (Prostanoid IP receptor) | 7 | AbortionArterial occlusive diseaseAsthma | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 1 | 0.40 | |||
| PI4KA | P42356 | Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67) (Phosphatidylinositol 4-Kinase III alpha) | Disease related genesEnzymesEssential proteins | Hereditary spastic paraplegia | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 1 | 0.40 | |||
| PIGB | Q92521 | GPI alpha-1,2-mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B) | Disease related genesHuman disease related genesMetabolic proteins | 9 | Epilepsy | Metabolism mediation | 1 | 0.40 | ||
| PITM3 | Q9BZ71 | Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3) (PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1) (NIR-1) | Disease related genesHuman disease related genesPredicted intracellular proteins | Cone-rod dystrophy | Fusion and delivery mediationMetabolism mediation | 1 | 0.40 | |||
| PKP1 | Q13835 | Plakophilin-1 (Band 6 protein) (B6P) | Disease related genesHuman disease related genesPlasma proteins | Ectodermal dysplasia | Adhesion and uptake mediationFusion and delivery mediation | 1 | 0.40 | |||
| PLPL9 | O60733 | 85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (2-lysophosphatidylcholine acylhydrolase) (EC 3.1.1.5) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Palmitoyl-CoA hydrolase) (EC 3.1.2.2) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9) | Disease related genesEnzymesHuman disease related genes | 2 | DystoniaParkinson disease | Fusion and delivery mediationImmune mediationMetabolism mediation | 1 | 0.40 |